Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-((tert-butoxycarbonylamino)methyl)picolinic acid is a chemical compound characterized by a picolinic acid core with a tert-butoxycarbonylamino)methyl side chain. It has a molecular formula of C13H18N2O5 and a molecular weight of 282.29 g/mol. This molecule is widely recognized for its role as a building block in organic synthesis and peptide chemistry, where the tert-butoxycarbonylamino group acts as a protecting group for the amine functionality, facilitating selective reactions.

171670-07-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 171670-07-8 Structure
  • Basic information

    1. Product Name: 6-((tert-butoxycarbonylamino)methyl)picolinic acid
    2. Synonyms: 6-((tert-butoxycarbonylamino)methyl)picolinic acid
    3. CAS NO:171670-07-8
    4. Molecular Formula: C12H16N2O4
    5. Molecular Weight: 252.27
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 171670-07-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 446.1±40.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.222±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 1.02±0.50(Predicted)
    10. CAS DataBase Reference: 6-((tert-butoxycarbonylamino)methyl)picolinic acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: 6-((tert-butoxycarbonylamino)methyl)picolinic acid(171670-07-8)
    12. EPA Substance Registry System: 6-((tert-butoxycarbonylamino)methyl)picolinic acid(171670-07-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 171670-07-8(Hazardous Substances Data)

171670-07-8 Usage

Uses

Used in Organic Synthesis:
6-((tert-butoxycarbonylamino)methyl)picolinic acid is used as a building block for the synthesis of various organic compounds. Its unique structure allows for the selective reactions that are crucial in creating complex organic molecules.
Used in Peptide Chemistry:
In peptide chemistry, 6-((tert-butoxycarbonylamino)methyl)picolinic acid is utilized as a component in the assembly of peptides. The protecting group on the amine functionality is essential for controlling the reactivity during peptide bond formation.
Used in Pharmaceutical Production:
6-((tert-butoxycarbonylamino)methyl)picolinic acid is used as a key intermediate in the production of pharmaceuticals. Its versatility in organic synthesis makes it a valuable component in the development of new drugs.
Used in Agrochemical Development:
6-((tert-butoxycarbonylamino)methyl)picolinic acid is also used in the development of agrochemicals, where its reactivity and structural properties contribute to the creation of effective products for agricultural applications.
Used in Research and Development of New Chemical Entities:
6-((tert-butoxycarbonylamino)methyl)picolinic acid is employed in research settings for the exploration and development of new chemical entities. Its role in organic and peptide chemistry provides a foundation for innovative discoveries in the chemical sciences.

Check Digit Verification of cas no

The CAS Registry Mumber 171670-07-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,1,6,7 and 0 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 171670-07:
(8*1)+(7*7)+(6*1)+(5*6)+(4*7)+(3*0)+(2*0)+(1*7)=128
128 % 10 = 8
So 171670-07-8 is a valid CAS Registry Number.

171670-07-8Downstream Products

171670-07-8Relevant articles and documents

Enhancing Aromatic Foldamer Helix Dynamics to Probe Interactions with Protein Surfaces

Vallade, Ma?lle,Sai Reddy, Post,Fischer, Lucile,Huc, Ivan

, p. 5489 - 5498 (2018)

Dynamic helices that undergo exchange between P and M conformations can be used as sensors when their interactions with chiral substances results in a helix handedness bias. For instance, chiral induction in short helically folded aromatic oligoamides based on 8-amino-2-quinoline carboxylic acid (Q) has been used to detect interactions with proteins and nucleic acids. However, the stability of these helices in water increases rapidly with oligomer length to the extent that helix dynamics become too slow for sensing applications. We have developed an approach to enhance the helix dynamics of these oligomers through the introduction of more flexible 6-aminomethyl-2-pyridinecarboxylic acid units (P) while preserving helix integrity. A series of P/Q hybrid oligoamides were synthesized and their rate of helix handedness inversion was evaluated by monitoring induced circular dichroism so as to define the requirements to bring kinetics in a practical range for sequences as long as fourteen units. Proof of principle was then brought by confining such sequences at the surface of carbonic anhydrase and showing that protein-mediated helix handedness induction occurs.

Polysubstituted pyridine medical intermediate and synthetic method thereof

-

Paragraph 0047; 0058, (2016/10/08)

The invention belongs to the field of medicine intermediate technology, and specifically relates to a polysubstituted pyridine medical intermediate and a synthetic method thereof. The polysubstituted pyridine medical intermediate is a key intermediate in pharmaceutical synthesis, and has a huge market potential. The synthetic method has simple synthetic route, simple and easily available staring material, and has great meaning in synthesis of pyridine intermediate, development of pyridine medicament and research and development of novel medicament, and the product is cheap.

CYCLIC PEPTIDE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF

-

Page/Page column 41, (2016/08/23)

The present invention relates to a cyclic peptide compound, and a preparation method, pharmaceutical composition and use thereof. In particular, the cyclic peptide compound of the present invention has a structure as shown by general formula (I). The compound of general formula (I), and isomers, racemates, pharmaceutically acceptable salts, crystalline hydrates, solvates or mixtures thereof have a use in the preparation of medicaments for preventing or treating mammalian diseases associated with histone deacetylase dysregulations.

Dimeric self-assembly of pyridyl guanidinium carboxylates in polar solvents

Irfan Ashiq, Muhammad,Tesfatsion, Biniam F.,Gaggini, Francesca,Dixon, Sally,Kilburn, Jeremy D.

experimental part, p. 12387 - 12397 (2011/02/22)

A series of pyridyl guanidinium-carboxylates has been prepared and the dimeric self-assembly of these studied in H2O/DMSO mixtures, principally using dilution isothermal calorimetry. Compounds 5 and 6, incorporating an aromatic ring in the "tet

4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS

-

Page/Page column 56, (2008/06/13)

The invention relates to novel pyrimidine derivatives of Formula (I), which are efficacious inhibitors of protein kinases, in particular of one or more isoforms of the protein kinase B/Akt.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 171670-07-8